 
          Loading Pathway...
Error: Pathway image not found.
Hide 
    Pathway Description
      Tobramycin Action Pathway
Homo sapiens
            Drug Action Pathway
            
          Created: 2014-04-26
          Last Updated: 2025-01-29
        
          Tobramycin (also named aktob or tobi) is an aminoglycoside antibiotic that can be used to treat various gram-negative bacterial infections such as the species of Pseudomonas. Bacterial 30S ribosomal subunit protein and four nucleotides of 16S rRNA will be bound with tobramycin irreversibly to cause misreading of mRNA; so that formation of mRNA could be prevented because of incorrect insertion of amino acids to polypeptide will result nonfunctional or toxic peptides. Therefore, there is no protein synthesis for bacteria.
        
      References
      
      Tobramycin Pathway References
Anwar H, Costerton JW: Enhanced activity of combination of tobramycin and piperacillin for eradication of sessile biofilm cells of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1990 Sep;34(9):1666-71.
                  Pubmed: 2126686
              Highlighted elements will appear in red.
        
          
          
        
      
      Highlight Compounds
      Highlight Proteins
      
          No Proteins Present
      
    Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
        
          
          
        
      
      Visualize Compound Data
      Visualize Protein Data
      
          No Proteins Present
      
    Downloads
      
    Settings